We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Abacavir

Abacavir | CAS NO: 136470-78-5, Abacavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood.

We are the Synchemia Research Chemical specializes in  supplying of  Abacavir  impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Abacavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Abacavir is in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). It works by decreasing the amount of HIV in the blood.. Buy Reliable and High-Purity Abacavir Impurities, Delivered by Synchemia Research Chemicals.

download image Download catalogue

Pharmaceutical Reference Standards

Abacavir
Abacavir
CAT No SRC-A721
CAS No 136470-78-5
Mol.F. C14H18N6O
Mol.Wt. 286.3g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir EP Impurity A
Abacavir EP Impurity A
CAT No SRC-A722
CAS No 136470-79-6
Mol.F. C14H18N6O
Mol.Wt. 286.3g/mole
INV STATUS IN STOCK
Abacavir EP Impurity B
Abacavir EP Impurity B
CAT No SRC-A723
CAS No 1443421-69-9
Mol.F. C18H21ClN10O
Mol.Wt. 428.9g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir EP Impurity C
Abacavir EP Impurity C
CAT No SRC-A724
CAS No 124752-25-6
Mol.F. C11H14N6O
Mol.Wt. 246.3g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir EP Impurity D
Abacavir EP Impurity D
CAT No SRC-A725
CAS No 1443421-67-7
Mol.F. C14H18N6O
Mol.Wt. 286.3g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir EP Impurity E
Abacavir EP Impurity E
CAT No SRC-A726
CAS No 208762-35-0
Mol.F. C14H20N6O
Mol.Wt. 288.4g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir EP Impurity F
Abacavir EP Impurity F
CAT No SRC-A727
CAS No 1443421-68-8
Mol.F. C18H26N6O
Mol.Wt. 342.4g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 1
Abacavir Impurity 1
CAT No SRC-A728
CAS No 2022943-79-7
Mol.F. C11H14ClN5O
Mol.Wt. 267.8g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 2
Abacavir Impurity 2
CAT No SRC-A729
CAS No 55482-22-9
Mol.F. C4H4N4O3
Mol.Wt. 156.1g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 3
Abacavir Impurity 3
CAT No SRC-A730
CAS No NA
Mol.F. C12H12ClN5O2
Mol.Wt. 293.8g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 4
Abacavir Impurity 4
CAT No SRC-A731
CAS No 141271-12-7
Mol.F. C10H14ClN5O
Mol.Wt. 255.7g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 7
Abacavir Impurity 7
CAT No SRC-A732
CAS No 171887-02-8
Mol.F. C7H9Cl2N5
Mol.Wt. 234.1g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 8
Abacavir Impurity 8
CAT No SRC-A733
CAS No 171887-01-7
Mol.F. C10H14Cl2N6
Mol.Wt. 289.2g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 9
Abacavir Impurity 9
CAT No SRC-A734
CAS No NA
Mol.F. C5H4ClN5O2
Mol.Wt. 201.6g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 10
Abacavir Impurity 10
CAT No SRC-A735
CAS No 1233918-37-0
Mol.F. C6H11NO
Mol.Wt. 113.2g/mole
INV STATUS CUSTOM SYNTHESIS
Abacavir Impurity 11
Abacavir Impurity 11
CAT No SRC-A736
CAS No 159832-22-1
Mol.F. C8H11N3O2
Mol.Wt. 181.2g/mole
INV STATUS CUSTOM SYNTHESIS
black arrow Previous 123 Next black arrow

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.